2018 annual financial data

Sarepta Therapeutics, Inc. 2018 Operating margin

Sarepta Therapeutics, Inc. 2018 operating margin with verified reported values.

Direct answer

Operating margin was -114.15%.

Operating income was -343,628,000 USD and net income was -361,918,000 USD.
Operating cash flow was -388,660,000 USD.

Get free Sarepta Therapeutics, Inc. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
301,034,000 USD
Operating income
-343,628,000 USD
Net income
-361,918,000 USD
Operating cash flow
-388,660,000 USD